To Homepage

Select your language

Die Inhalte dieser Seite sind auch auf Deutsch verfügbar.

Auf Deutsch ansehen
WITH OUR EXPERTISE Realize the full potential of your oligonucleotide program
Global leader in oligonucleotide manufacturing & analysis

The BioSpring Advantage

BioSpring, an industry-leading expert in nucleic acid science and technology, delivers therapeutic-quality oligonucleotides at all production scales,  spanning the complete drug development lifecycle. Our aim is a highly collaborative partnership to unleash the full potential of our clients' technology - accelerating breakthrough therapies to meet their commercial promise.

Clients can rely on our precision and strict cGMP compliance – guided by expertise, passion for innovation and more than 27 years of experience.

Learn more about our nucleic acid services
From one Source

At Any Scale

We support our clients from early small-/mid-scale manufacture of their drug development candidates to late-stage clinical and commercial manufacturing, including all related analytical activities.

  • cGMP manufacturing for clinical Phase I – III: Multiple-hundred kg annual capacity
  • Process validation and commercial manufacture
  • Manufacturing of nucleic acids for R&D, as well as lead candidate screening and development
  • Process development – more than 140 successful programs each year
  • Scale-up, scale-down and process transfer
  • Pre-clinical non-GMP batch manufacture
  • Regulatory tox batch manufacture
  • Generation of reference standards
The complete Lifecycle

Nucleic Acid Manufacturing and analysis0002

Unleash the full potential of your nucleic acid programs! Contact us